Trials / Unknown
UnknownNCT01937754
Study of the Effects of an Oral Nitric Oxide Supplement on Blood Pressure in Prehypertensive Adults
Study of the Effects of an Oral Nitric Oxide Supplement on Functional Capacity and Blood Pressure in Healthy Adults With Prehypertension
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Neogenis Laboratories · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Oral supplementation of Neo40(TM), a nitrate lozenge, will reduce blood pressure in healthy adults with clinical prehypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Nitric Oxide supplement | Lozenge consisting of beetroot and 75 mg caffeine |
| DIETARY_SUPPLEMENT | Placebo | Same form factor and flavor as test lozenge but contains no active ingredients |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-09-01
- First posted
- 2013-09-10
- Last updated
- 2013-09-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01937754. Inclusion in this directory is not an endorsement.